{"product_id":"atryshealth-business-model-canvas","title":"Atrys Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock Healthcare Diagnostics Business Model Canvas — Ready-to-Use Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock Atrys’s full Business Model Canvas to see exactly how the company creates value, scales services, and captures healthcare and diagnostics market share. This concise, actionable canvas breaks down customer segments, revenue streams, partnerships and cost structure—ready in Word and Excel. Purchase the complete file for a practical, ready-to-use strategic blueprint ideal for investors, consultants, and founders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartner with public and private hospitals to integrate diagnostics, imaging and oncology workflows, leveraging Atrys networks expanded in 2024 to deepen clinical ties across Spain and Latin America.\u003c\/p\u003e\n\u003cp\u003eCo-develop care pathways and referral protocols to streamline patient intake and reduce delays between diagnosis and treatment.\u003c\/p\u003e\n\u003cp\u003eEnable integrated data exchange with shared quality metrics and support multi-site coverage to ensure continuity of care across hospital networks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and research institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborate with academic and research institutions on clinical trials, genomics research, and validation studies to access novel biomarkers, advanced imaging protocols, and robust evidence generation. Co-author peer-reviewed publications to strengthen clinical credibility and market acceptance. Leverage 2024 research funding streams such as Horizon Europe and institutional grants to subsidize trials and use shared research infrastructure for scale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and AI vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eForm alliances with AI, cloud and cybersecurity providers to scale Atrys platforms, tapping a healthcare AI market that surpassed $20B in 2024 and a global cloud services market above $600B. Integrate best-in-class imaging, pathology and genomics algorithms to raise diagnostic accuracy and throughput. Ensure interoperable, regulatory-grade data pipelines to accelerate product roadmaps and cut time-to-market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical device and pharma companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAtrys partners with medical device and pharma firms to provide companion diagnostics, theranostics, and treatment-planning tools, supporting biomarker-driven patient selection for trials and commercialization; global companion diagnostics market ~6.3 billion USD in 2024. Co-creation of post-market evidence and RWD programs strengthens regulatory positioning and safety signals while joint commercialization expands distribution and revenue reach.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCompanion diagnostics: co-development\u003c\/li\u003e\n\u003cli\u003eBiomarker-based patient selection: trial enrichment\u003c\/li\u003e\n\u003cli\u003eRWD\/post-market: evidence generation\u003c\/li\u003e\n\u003cli\u003eJoint commercialization: channel expansion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers and health systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAtrys partners with payers and health systems to align on value-based care and reimbursement pathways, pilot bundled payments for diagnostics and oncology episodes, and share risk through outcome-based contracts tied to clinical benchmarks while integrating services into payer networks and formularies to improve access.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eValue-based alignment\u003c\/li\u003e\n\u003cli\u003eBundled diagnostics\/onco pilots\u003c\/li\u003e\n\u003cli\u003eOutcome-based risk sharing\u003c\/li\u003e\n\u003cli\u003ePayer network integration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrate diagnostics, imaging and oncology across Spain \u0026amp; LATAM in \u003cstrong\u003e2024\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartner with public\/private hospitals to integrate diagnostics, imaging and oncology workflows, leveraging Atrys network expansion in 2024 across Spain and Latin America.\u003c\/p\u003e\n\u003cp\u003eCo-develop care pathways, referral protocols and shared data exchange to shorten diagnosis-to-treatment times and ensure multi-site continuity.\u003c\/p\u003e\n\u003cp\u003eAlliances with AI\/cloud\/cybersecurity vendors and pharma\/device firms accelerate regulatory-grade algorithms and companion diagnostics; healthcare AI market ~$20B (2024), cloud ~$600B (2024), companion dx ~$6.3B (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI market\u003c\/td\u003e\n\u003ctd\u003e$20B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud market\u003c\/td\u003e\n\u003ctd\u003e$600B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompanion dx\u003c\/td\u003e\n\u003ctd\u003e$6.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for Atrys covering all nine BMC blocks—customer segments, value propositions, channels, revenue streams, key partners, activities, resources and cost structure—with practical insights, competitive advantages and linked SWOT for investor-ready presentations and strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas for Atrys that quickly highlights how the company alleviates healthcare and biotech operational pain points—streamlining diagnostics, data services, and patient pathways. Perfect for teams and boards to condense strategy, speed decision-making, and compare business pivots side-by-side.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced diagnostics operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRun integrated imaging, pathology and genomics labs under standardized ISO 15189 protocols, with centralized sample logistics and QA to target 24–72 hour diagnostic turnarounds. Maintain external proficiency testing (EQA) and national accreditation programs to ensure traceability and regulatory compliance. Continuously expand and update test menus and digital reporting workflows in 2024 to include novel biomarkers and structured genomic reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI model development and validation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBuild and validate algorithms for image analysis, triage, and decision support, following EU MDR and post‑market surveillance requirements in force through 2024 to enable clinical deployment.\u003c\/p\u003e\n\u003cp\u003eCurate governed, labeled datasets with traceability and consent controls, aligning with GDPR and clinical audit standards used across Atrys’ Spain and Latin America operations.\u003c\/p\u003e\n\u003cp\u003eConduct bias, accuracy, and robustness testing with clinical partners, then deploy models into workflows with continuous monitoring and performance logging for regulatory reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadiation oncology planning and delivery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProvide comprehensive treatment planning, contouring, and dosimetry services to design patient-specific radiotherapy protocols. Operate linear accelerators and implement QA systems where applicable to ensure delivery accuracy and safety. Integrate multimodality imaging and genomics to personalize dose, fractionation, and target selection. Continuously track outcomes and toxicity metrics to refine protocols and improve quality of care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTelemedicine and remote monitoring\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAtrys delivers virtual consultations, second opinions and scheduled follow-ups while integrating CE-marked remote devices and mobile apps to continuously track vitals and adherence; clinical alerts trigger escalation to in-person care when predefined thresholds are crossed. All communications and data handling comply with GDPR for Spain, ensuring encrypted channels and strict access controls to protect patient privacy.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVirtual consults, second opinions, follow-ups\u003c\/li\u003e\n\u003cli\u003eCE-marked devices and apps for vitals\/adherence\u003c\/li\u003e\n\u003cli\u003eEscalation on clinical thresholds\u003c\/li\u003e\n\u003cli\u003eGDPR-compliant encrypted communication\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory, quality, and data governance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAtrys maintains ISO, CAP, CLIA, MDR and GDPR compliance across operations, implements SOPs, routine audits and incident response, manages consent, de‑identification and data lineage, and reports performance and safety to clinicians and investors; GDPR exposure can be fines up to €20 million or 4% of global turnover, covering ~447 million EU citizens.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCompliance: ISO, CAP, CLIA, MDR, GDPR\u003c\/li\u003e\n\u003cli\u003eControls: SOPs, audits, incident response\u003c\/li\u003e\n\u003cli\u003eData: consent, de‑identification, lineage\u003c\/li\u003e\n\u003cli\u003eReporting: performance \u0026amp; safety to stakeholders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e24–72h ISO 15189 labs, CE\/MDR AI imaging, GDPR fines up to €20 million\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOperate ISO 15189 labs with centralized logistics targeting 24–72h diagnostics, expand test menus and structured genomic reports in 2024, and maintain EQA accreditation. Develop CE\/MDR‑aligned AI for image analysis with continuous post‑market surveillance and clinical monitoring. Deliver radiotherapy planning, remote consults and CE devices with GDPR controls; GDPR fines up to €20 million or 4% turnover covering ~447M EU citizens.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 target\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\u003ctr\u003e\n\u003ctd\u003eTurnaround\u003c\/td\u003e\n\u003ctd\u003e24–72h\u003c\/td\u003e\n\u003c\/tr\u003e\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Atrys Business Model Canvas you’re previewing is the actual deliverable, not a mockup or sample. Upon purchase you’ll receive the same complete, editable file formatted exactly as shown, ready for presentation and use. No hidden pages or placeholders—what you see here is what you’ll download and own.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56161765425529,"sku":"atryshealth-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/atryshealth-business-model-canvas.png?v=1762695700","url":"https:\/\/portersfiveforce.com\/products\/atryshealth-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}